WELLBUTRIN XL (Page 8 of 8)

PRINCIPAL DISPLAY PANEL — 150 mg Tablet Bottle Label

NDC 0187-0730-90

Rx only

ONCE-DAILY
Wellbutrin XL ®
(bupropion hydrochloride
extended-release tablets)

150 mg
30 Tablets

WARNING: Do not use with other medicines
that contain bupropion hydrochloride.

Federal Law requires dispensing
of Wellbutrin XL ® with the Medication Guide under this label.

Wellbutrin 150mg label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 300 mg Tablet Bottle Label

NDC 0187-0731-30

Rx only

ONCE-DAILY
Wellbutrin XL ®
(bupropion hydrochloride
extended-release tablets)

300 mg
30 Tablets

WARNING: Do not use with other medicines
that contain bupropion hydrochloride.

Federal Law requires dispensing
of Wellbutrin XL ® with the Medication Guide under this label.

WELLBUTRIN 300MG LABEL
(click image for full-size original)
WELLBUTRIN XL bupropion hydrochloride tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0187-0730
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BUPROPION HYDROCHLORIDE (BUPROPION) BUPROPION HYDROCHLORIDE 150 mg
Inactive Ingredients
Ingredient Name Strength
ETHYLCELLULOSE, UNSPECIFIED
GLYCERYL DIBEHENATE
POLYVINYL ALCOHOL, UNSPECIFIED
POLYETHYLENE GLYCOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
SILICON DIOXIDE
TRIETHYL CITRATE
METHACRYLIC ACID — METHYL METHACRYLATE COPOLYMER (1:1)
Product Characteristics
Color WHITE (creamy white to pale yellow) Score no score
Shape ROUND Size 7mm
Flavor Imprint Code WELLBUTRIN;XL;150
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0187-0730-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:0187-0730-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE None
3 NDC:0187-0730-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021515 08/29/2003
WELLBUTRIN XL bupropion hydrochloride tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0187-0731
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BUPROPION HYDROCHLORIDE (BUPROPION) BUPROPION HYDROCHLORIDE 300 mg
Inactive Ingredients
Ingredient Name Strength
ETHYLCELLULOSE, UNSPECIFIED
GLYCERYL DIBEHENATE
POLYVINYL ALCOHOL, UNSPECIFIED
POLYETHYLENE GLYCOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
SILICON DIOXIDE
TRIETHYL CITRATE
METHACRYLIC ACID — METHYL METHACRYLATE COPOLYMER (1:1)
Product Characteristics
Color WHITE (creamy white to pale yellow) Score no score
Shape ROUND Size 9mm
Flavor Imprint Code WELLBUTRIN;XL;300
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0187-0731-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:0187-0731-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021515 08/29/2003
Labeler — Bausch Health US LLC (831922468)
Establishment
Name Address ID/FEI Operations
Bausch Health Companies, Inc. 253292734 MANUFACTURE (0187-0730), MANUFACTURE (0187-0731)

Revised: 07/2021 Bausch Health US LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.